药物资讯

Vol.5 No.1 (February 2016)

阿尔茨海默病治疗相关靶点研究进展
Research Progress for Relative Treatment Targets in Alzheimer’s Disease

 

作者:

诸丽华 , 何 玲 :中国药科大学,药学院,药理系,江苏 南京

 

关键词:

阿尔茨海默病神经递质G蛋白偶联受体Alzheimer’s Disease Neurotransmitter G Protein-Coupled Receptors

 

摘要:

阿尔茨海默病(Alzheimer’s disease, AD)是一种以认知障碍为主要特征的退行性神经疾病。神经元和突触损伤伴随神经递质功能异常,以及Aβ沉积和神经纤维缠结一直被认为是AD的主要标记。但由于病因复杂,目前针对该疾病仍无有效的治疗手段。本文将从中枢神经系统主要的神经递质及其受体方面对阿尔茨海默病治疗相关靶点进行综述。

Alzheimer’s disease is neurodegenerative disease mainly characterized by cognitive impairment. Neuron and synapse loss together with neurotransmitter dysfunction have, along with Abdeposition and neurofibrillary tangles, been recognized as hallmarks of AD. However, there is still no a curative treatment for this devastating disease due to complexity of the pathophysiology of the disease. This article reviews relative treatment targets in Alzheimer’s disease from the aspects of main neurotransmitter and receptors in the central nervous system.

文章引用:

诸丽华 , 何 玲 (2016) 阿尔茨海默病治疗相关靶点研究进展。 药物资讯, 5, 1-7. doi: 10.12677/PI.2016.51001

 

参考文献

分享
Top